Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
This study has been completed.
Study NCT00002742 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infection
Leukemia
Lymphoma
Myelodysplastic Syndromes
Additional conditions recognized in this trial
Communicable Diseases
Multiple Myeloma
Myeloproliferative Disorders
Neoplasms
Neoplasms, Plasma Cell
Preleukemia
Syndrome
More general conditions related to this trial
Blood Protein Disorders
Bone Marrow Diseases
Cardiovascular Diseases
Disease
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Paraproteinemias
Pathologic Processes
Precancerous Conditions
Vascular Diseases
Interventions listed in this trial
amphotericin B deoxycholate
nystatin
Additional drug interventions recognized in this trial
Abelcet
Amphotericin B
Amphotericin B-deoxycholate
Antifungal Agents
Deoxycholic Acid
Liposomal amphotericin B
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antifungal
Antiparasitic Agents
Antiprotozoal Agents
Cholagogues and Choleretics
Gastrointestinal Agents
Ionophores
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Aronex Pharmaceuticals
Back to top of Main Content
